MICRONIZED TANAPROGET, COMPOSITION AND ITS PREPARATION METHOD

Title:

MICRONIZED TANAPROGET, COMPOSITION AND ITS PREPARATION METHOD

Document Type and Number:

Japanese Patent JP2013006840

Kind Code:

A

Abstract:

To provide a medical composition containing micronized tanaproget.

The composition contains: crystalline cellose; croscarmellose sodium; anhydrous lactose; magnesium stearate; micronized calcium disodium edetate; and micronized sodium thiosulfate pentahydrate. The composition is effective for anticonception and hormone replacement therapy, also effective for the treatment and/or prevention of the hormone dependent tumor of myometrium fibroid, benign prostatic hypertrophy, benign and malign neoplastic disease, dysfunctional bleeding, uterine leiomyomas, endometriosis, polycystic ovary syndrome, cancer and adenocarcinoma of pituitary, endometrium, kidney, ovary, breast, prostate and others, and also effective for the preparation of medicines useful for those diseases. As further usage, the stimulation of food ingestion is included.

More Like This:

WO/2005/067933	1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D) (1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
JP6666264	Preparation of novel stable antibody drug conjugate and its application
JP5523430	Cyclothiocarbamate derivative as a progesterone receptor modulator

Inventors:

NAGI ARWINDER
CHATLAPALLI RAMARAO
HASAN SHAMIM
GHORAB MOHAMED
GAGLANI DHAVAL

Application Number:

JP2012169771A

Publication Date:

January 10, 2013

Filing Date:

July 31, 2012

Export Citation:

Click for automatic bibliography generation Help

Assignee:

WYETH LLC

International Classes:

A61K31/536; A61K9/16; A61K9/20; A61K9/30; A61K9/36; A61K47/12; A61K47/18; A61K47/20; A61K47/26; A61K47/38

Domestic Patent References:

JP2008539264A	2008-11-13
JP2008539262A	2008-11-13
JP2008539258A	2008-11-13
JP2008539254A	2008-11-13
JP2008510722A	2008-04-10
JP2008509917A	2008-04-03
JP2008509217A	2008-03-27
JP2008509216A	2008-03-27
JP2008505909A	2008-02-28
JP2007534767A	2007-11-29
JP2007534760A	2007-11-29
JP2005535628A	2005-11-24
JP2005535624A	2005-11-24
JP2002543192A	2002-12-17
JP2002543192A	2002-12-17

Foreign References:

US20040265355A1

2004-12-30

Other References:

JPN6012004340; 橋田充編: 経口投与製剤の設計と評価 , 19950210, ｐ．８１〜８５, 株式会社薬業時報社
JPN6012004342; 日本医薬品添加剤協会編: 医薬品添加物事典 , 19940114, ｐ．１７，４６，４９，７２，８２，１２４，１３３，１４４，２１４, 株式会社薬事日報社
JPN6012004340; 橋田充編: 経口投与製剤の設計と評価 , 19950210, ｐ．８１〜８５, 株式会社薬業時報社
JPN6012004342; 日本医薬品添加剤協会編: 医薬品添加物事典 , 19940114, ｐ．１７，４６，４９，７２，８２，１２４，１３３，１４４，２１４, 株式会社薬事日報社

Attorney, Agent or Firm:

Hiroshi Kobayashi
Norio Omori
Yasuhito Suzuki

Previous Patent: PERINDOPRIL

Next Patent: PANCREATIC POLYPEPTIDE FAMILY MOTIF, POLYPEPTIDE AND METHOD COMPRISING THE SAME